- Home
- CRC vs VKTX Comparison
CRC vs VKTX Comparison
Compare CRC & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRC | VKTX |
|---|---|---|
| Founded | 2014 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 3.8B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | CRC | VKTX |
|---|---|---|
| Price | $46.84 | $36.29 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 14 |
| Target Price | $63.70 | ★ $87.07 |
| AVG Volume (30 Days) | 811.8K | ★ 2.9M |
| Earning Date | 11-04-2025 | 02-04-2026 |
| Dividend Yield | ★ 3.35% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.29 | N/A |
| Revenue | ★ $3,505,000,000.00 | N/A |
| Revenue This Year | $20.33 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $11.26 | ★ N/A |
| Revenue Growth | ★ 34.91 | N/A |
| 52 Week Low | $30.97 | $18.92 |
| 52 Week High | $58.41 | $49.67 |
Technical Indicators
Market Signals| Indicator | CRC | VKTX |
|---|---|---|
| Relative Strength Index (RSI) | 44.73 | 49.22 |
| Support Level | $46.42 | $36.49 |
| Resistance Level | $48.91 | $38.50 |
| Average True Range (ATR) | 1.18 | 1.85 |
| MACD | 0.07 | -0.07 |
| Stochastic Oscillator | 34.98 | 42.75 |
Price Performance
Historical ComparisonAbout CRC California Resources Corporation
California Resources Corp is an independent oil and natural gas exploration and production company operating properties exclusively within California. It provides affordable and reliable energy in a safe and responsible manner, to support and enhance the quality of life of Californians and the local communities in which the company operates. It has some of the lowest carbon intensity production in the United States and is focused on maximizing the value of its land, mineral, and technical resources for decarbonization by developing carbon capture and storage (CCS) and other emissions-reducing projects.
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.